Verrica Pharmaceuticals buy Needham & Company LLC
Start price
14.05.24
/
50%
€9.90
Target price
14.05.25
€14.81
Performance (%)
-32.93%
Price
22.07.24
€6.46
Summary
This prediction is currently active. Massive losses of -32.93% have been the result for the BUY prediction by Needham___Company_LL. This prediction currently runs until 14.05.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Verrica Pharmaceuticals | -9.973% | -9.973% |
iShares Core DAX® | -0.543% | 1.491% |
iShares Nasdaq 100 | -2.696% | -1.235% |
iShares Nikkei 225® | -2.863% | 2.491% |
iShares S&P 500 | -1.105% | 0.013% |
Comments by Needham___Company_LL for this prediction
In the thread Discuss Verrica Pharmaceuticals
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its price target raised by analysts at Needham & Company LLC from $8.00 to $16.00. They now have a "buy" rating on the stock.
Ratings data for VRCA provided by MarketBeat
Stopped prediction by Needham___Company_LL for Verrica Pharmaceuticals
Verrica Pharmaceuticals
Start price
Target price
Perf. (%)
€2.74
10.11.23
10.11.23
€7.49
10.11.24
10.11.24
132.30%
22.07.24
22.07.24
Verrica Pharmaceuticals
Start price
Target price
Perf. (%)
€3.90
23.08.23
23.08.23
€9.25
23.08.24
23.08.24
85.77%
22.07.24
22.07.24